Serum levels of hK11 and hK13 were significantly higher (P < 0.05) in serum from prostate cancer patients at T0 with respect to healthy controls (Figure 4 and Table 3), similarly to PSA (Figure 5). Here, KLK11 is linked to prostate carcinoma.